SCHEMBL8277282

SCHEMBL8277282

COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1C1CN=CO1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 6/20 0.66
IMPDH1 P20839 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGER1 P34995 1/20 0.35
QPCT Q16769 2/20 0.35
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
AURKB Q96GD4 1/20 0.35
PDE4D Q08499 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
ADORA2A P29274 1/20 0.34
HIF1A Q16665 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172475 0.88 IMPDH2 (0.55) IMPDH2IMPDH1LMNAPTGER1MEN1
SCHEMBL14065071 0.84 IMPDH2 (0.45) IMPDH2IMPDH1L3MBTL1LMNASMN1; SMN2
SCHEMBL14065171 0.80 IMPDH2 (0.49) IMPDH2IMPDH1L3MBTL1LMNASMN1; SMN2
SCHEMBL12154536 0.79 IMPDH2 (0.76) IMPDH2IMPDH1L3MBTL1QPCT
Merimepodib SCHEMBL29376593 0.79 IMPDH2 (1.00) IMPDH2IMPDH1
SCHEMBL12300178 0.79 IMPDH2 (0.71) IMPDH2IMPDH1L3MBTL1PTGER1QPCT
Merimepodib SCHEMBL329923 0.79 IMPDH2 (1.00) IMPDH2IMPDH1
Merimepodib SCHEMBL329922 0.79 IMPDH2 (1.00) IMPDH2IMPDH1
Merimepodib SCHEMBL29591763 0.79 IMPDH2 (1.00) IMPDH2IMPDH1
SCHEMBL13529966 0.79 IMPDH2 (0.71) IMPDH2IMPDH1L3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005077969-A2 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-08-25 WO disclosed
WO-2005037274-A1 COMBINATION THERAPY FOR HCV INFECTION VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-04-28 WO disclosed